Paula Ragan
President and CEO at X4 Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: X4 Pharmaceuticals Inc., 3 years.
X4 Pharmaceuticals Inc.
Director · President and CEO
CAMP4 Therapeutics Corporation
Director
Chief executive roles
X4 Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 15, 2024 | X4 Pharmaceuticals Inc. | Open-market sale | −31,897 | $0.39 | $12,440 |
| Oct 15, 2024 | X4 Pharmaceuticals Inc. | Open-market sale | −31,897 | $0.56 | $17,862 |
| Oct 7, 2024 | X4 Pharmaceuticals Inc. | Open-market sale | −239,436 | $0.55 | $131,690 |
| Oct 4, 2024 | X4 Pharmaceuticals Inc. | Grant or award | +532,081 | — | — |
| Mar 11, 2024 | X4 Pharmaceuticals Inc. | Open-market sale | −49,678 | $0.88 | $43,717 |
| Feb 12, 2024 | X4 Pharmaceuticals Inc. | Open-market sale | −21,695 | $1.01 | $21,912 |
| Nov 3, 2023 | X4 Pharmaceuticals Inc. | Open-market sale | −39,906 | $0.90 | $35,915 |
| Nov 1, 2023 | X4 Pharmaceuticals Inc. | Open-market sale | −199,531 | $0.73 | $145,658 |
| Oct 31, 2023 | X4 Pharmaceuticals Inc. | Grant or award | +532,081 | — | — |
| Jun 23, 2023 | X4 Pharmaceuticals Inc. | Open-market sale | −6,724 | $1.92 | $12,910 |
| Jun 15, 2023 | X4 Pharmaceuticals Inc. | Open-market sale | −6,724 | $2.23 | $14,995 |
| May 31, 2023 | X4 Pharmaceuticals Inc. | Open-market sale | −6,292 | $1.95 | $12,269 |
| Mar 10, 2023 | X4 Pharmaceuticals Inc. | Open-market sale | −49,678 | $0.84 | $41,730 |
| Feb 13, 2023 | X4 Pharmaceuticals Inc. | Open-market sale | −21,695 | $0.93 | $20,176 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.